Publicacions en col·laboració amb investigadors/es de AstraZeneca (United Kingdom) (5)

2019

  1. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 2, pp. 173-183

  2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2016

  1. Effect of Pre-Hospital Ticagrelor during the First 24 h after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction the ATLANTIC-H24 Analysis

    JACC: Cardiovascular Interventions, Vol. 9, Núm. 7, pp. 646-656

2014

  1. Eficiencia de la combinación naproxeno/esomeprazol para el tratamiento de la artrosis en España

    Reumatologia Clinica, Vol. 10, Núm. 4, pp. 210-217

2003

  1. The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice

    Journal of Physiology, Vol. 550, Núm. 3, pp. 921-926